Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by BearDownAZ


T.RVX

RE:RE:RE:BEAR-Re News Release

G1945V, Let me answer your questions in a different way. ASSERT, SUSTAIN...

March 15, 2017

T.RVX

RE:BEAR-Re News Release

I'm pretty sure it refers to the two drugs (RVX-208 and rosuvastatin...

March 15, 2017

ESPR

Initiation of Phase 2 Triplet Oral Therapy Trial

Esperion Announces Initiation of Phase 2 Triplet Oral Therapy Study of...

March 7, 2017

ESPR

Esperion Oral Presentation at ACC 2017 Meeting

Esperion Announces Oral Presentation on Genetic Validation of ATP Citrate...

March 6, 2017

T.RVX

RE:RE:RE:RE:RE:RE:Epigenetics General

Pan BET inhibitors refer to an inhibitor that binds equally well with high...

March 4, 2017

T.RVX

RE:RE:RE:RE:Epigenetics General

Toniv, I am very anxious to hear more concrete info about the ZEN-3694...

March 3, 2017

T.RVX

RE:RE:Epigenetics General

There are many companies with pan BET inhibitors that are NOT selective for...

March 2, 2017

T.RVX

Resverlogix: The Science Is Getting 'BETter' For RVX208

BKC just posted a new Seeking Alpha article entitled: Resverlogix: The...

February 27, 2017

T.RVX

RE:First MACE event-Primary Objective ?

You are way oversimplifying it GV. It is NOT a race to the FIRST MACE event...

February 27, 2017

T.RVX

RE:microbiome

Resverlogix first presented on a microbiome-related theme back in September...

February 25, 2017

T.RVX

RE:RE:RE:RE:News Release Issued: Feb 13, 2017 (5:00am MST)

Yes and yes

February 21, 2017

V.BTI.H

Armagen reports early positive Phase II data for AGT-181

Let's try that again. Trial shows ArmaGen biologic improves cognition in...

February 17, 2017

V.BTI.H

Armagen reports early positive Phase II data for AGT-181

[url=Trial shows ArmaGen biologic improves cognition in Hurler syndrome...

February 17, 2017

T.RVX

RE:RE:News Release Issued: Feb 13, 2017 (5:00am MST)

I'm not sure if this is the only patent, but this one from St. Louis...

February 13, 2017

T.RVX

RE:RE:RE:RE:J & J XARELTO

XARELTO  that is used for other medical ailments as we see advertised on...

February 12, 2017

T.RVX

RE:RE:J & J XARELTO

Toniv, Thanks for sharing about the early stop of the COMPASS trial. BTW...

February 11, 2017

T.RVX

RE:New email from RVX

A January 11th, 2017 video is too old for you? Really?

February 9, 2017

T.RVX

Resverlogix's 2017 Outlook Video

Resverlogix’s President and CEO Mr. Donald McCaffrey had the opportunity to...

February 9, 2017

T.RVX

RE:New video by RVX

Thanks for sharing this "new" video JK, but it was first released...

February 9, 2017

T.RVX

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Moved up those "pinks" at the last one minute

Thanks Led for linking to that previous post. 3-point MACE only includes the...

February 8, 2017